PPARG and type 2 diabetes mellitus: Thiazolidinediones, peroxisome proliferator-activated receptor-gamma (PPAR-γ) activator, are compounds that enhance insulin sensitivity, effectively reducing plasma glucose levels and improving the lipid profile of individuals with type 2 diabetes [232].